$150K — $200K *
Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need. Fulcrum’s proprietary patient-focused product engine is designed to systematically identify and validate cellular drug targets that can modulate gene expression to treat the root cause of genetically defined rare diseases. The Company has advanced losmapimod to Phase 2 clinical development for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and is advancing losmapimod to Phase 3 for the treatment of COVID-19. Fulcrum also anticipates a regulatory filing in the second half of 2020 with FTX-6058 for the treatment of sickle cell disease.
Reporting to the Senior Director of Corporate Strategy & New Product Planning, this position will collaborate closely with a cross-functional team including research, clinical development, business development, and senior leadership to drive key business decisions around Fulcrum’s pipeline assets and discovery programs. This role offers the candidate the ability to shape the long-term success of the Fulcrum portfolio by providing market, competitive, and commercial insights to inform strategic decisions. The ideal candidate will be eager to assist in building out the NPP and early commercial functions within a growing clinical stage company.
Valid through: 1/21/2021